Data Conversion Laboratory Logo
  • Industries

    • Associations
    • Defense
    • Financial & Insurance
    • Government
    • Health & Pharmaceutical
    • Legal
    • Libraries-Museums-Universities
    • Manufacturing & Technology
    • Publishing & Training
  • Services

    • Accessibility
    • Artificial Intelligence
    • Data Conversion
    • DITA Conversion
    • XML Conversion
    • EBook Conversion
    • Enrichment
    • Entity Extraction
    • Data Harvesting
    • QA Validation
    • Content Reuse Analysis
    • Structured Content Delivery
    • Structured Product Labeling
    • Training Sets
  • Solutions

    • Harmonizer
    • Chronos
    • Content Clarity
    • Discovery Bridge
    • DCL Data Harvester
    • DCL Reformer
  • Standards

    • XML
    • DITA
    • S1000D
    • SPL
    • PubMed - JATS - BITS
  • Resources

    • Customer Case Studies
    • Press Releases
    • Upcoming Webinars
    • On-Demand Webinars
    • White Papers
    • Surveys
  • About

    • About Us
    • Careers
    • Executive Leadership
    • Events
    • Timeline
    • Partners
    • Contact
    • Newsletter
  • Blog

  • More

    Use tab to navigate through the menu items.
    • All Posts
    • DITA
    • Harmonizer
    • Accessibility
    • Section 508
    • Big Data
    • AI
    • Data Harvesting
    • Web Scraping
    • DCL Data Harvester
    • NISO STS
    • XML
    • Conversion
    • Scholarly Publishing
    • S1000D
    • Frankfurt Book Fair
    • Digital Transformation
    • Content Reuse
    • Content Strategy
    • Metadata
    • Content Structure
    • JATS
    • SPL
    • Structured Product Labeling
    • SGML
    • XML Product Monographs
    • XML PM
    • PubMed
    • ebooks
    • Pharma
    Search
    What is GDUFA?
    Marianne Calilhanna
    • 2 min

    What is GDUFA?

    The Generic Drug User Fee Act (GDUFA) is a law designed to speed access to safe and effective generic drugs to the public, and reduce...
    Starting With the End in Mind
    lmazure
    • 2 min

    Starting With the End in Mind

    A guest blog post by Val Swisher, Founder and CEO of Content Rules, Inc. Once upon a time, actually many many years ago, I was doing a...
    Top Considerations for DITA 2.0
    Marianne Calilhanna
    • 2 min

    Top Considerations for DITA 2.0

    DITA 2.0 is coming. While we’ve heard the whispers for several years now, the specification truly is almost ready for public consumption....
    Beyond the Buzz – What Does Digital Transformation Mean to You?
    Marianne Calilhanna
    • 2 min

    Beyond the Buzz – What Does Digital Transformation Mean to You?

    As a seasoned marketing professional who utilizes best practices in an attempt to demonstrate thought leadership, I often find myself...
    Content Conversion: Building the Structure for Digital Transformation
    Marianne Calilhanna
    • 7 min

    Content Conversion: Building the Structure for Digital Transformation

    Reprinted with permission from "Content Transformation: Breathing New Life into Legacy Content" by Val Swisher and Regina Lynn Preciado...
    CARES Act Amount Information Reporting to FDA – What You Need to Know
    Marianne Calilhanna
    • 4 min

    CARES Act Amount Information Reporting to FDA – What You Need to Know

    IMPORTANT UPDATE: On February 14, 2022, the FDA designated the February 14 deadline as a recommendation and not a requirement. This...
    1
    2345

    Stay Up to Date with DCL!

    Learn about product updates, get company news, and receive our monthly newsletter. Click below and enter your info. We never share your information nor overwhelm your inbox!

    ​

    ​

    YOUR EMAIL

    ​

    Email Icon

    Data Conversion Laboratory

    61-18 190th Street, Suite 205

    Fresh Meadows, NY 11365

    ​

    +1 718.357.8700

    info@dclab.com

    • DCL LinkedIn
    • DCL Twitter
    • DCL YouTube
    PECD MS Certified

    HOME  /  INDUSTRIES  /   SOLUTIONS  /  SERVICES  /  RESOURCES /  ABOUT  /  CONTACT  /  PRIVACY  /  TERMS OF USE

    © 2022 Copyright Data Conversion Laboratory, All Rights Reserved.

    Back to Top Icon